| Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies. | |
| | |
MedLine Citation:
|
PMID: 20951511 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: Existing trials of varenicline have typically excluded smokers with concurrent medical and psychiatric illnesses and no data exist comparing effectiveness of varenicline with combination pharmacotherapy. This study evaluated abstinence and psychiatric outcomes of various tobacco dependence medications, including varenicline. METHODS: Retrospective cohort of 723 smokers, most with significant medical and psychiatric comorbidity, was evaluated at the UMDNJ-Tobacco Dependence Clinic from 2006 to 2008. Demographics, measures of tobacco dependence and co-morbidities, and a validated instrument measuring psychological distress (Kessler-6) were obtained. Primary outcome was 7-day point abstinence at 6 months after target quit date. RESULTS: Cessation medications used included combination pharmacotherapy (39%), single nicotine replacement therapy (NRT) or bupropion (29%), and varenicline (23%), with 9% using no medications. Overall, 23% of patients were abstinent at 6 months. In an adjusted regression model, smokers using varenicline or combination medications were more likely abstinent at 6 months than those using no medications (adjusted odds ratio=2.99; 95% confidence interval=1.20-7.47 and 2.80; 1.15-6.82, respectively), but not statistically higher than those using single medications (AOR=1.70). Age, gender, education, marital status, cigarettes per day, time to first cigarette, night smoking, and menthol smoking were not significantly related to abstinence. Varenicline or combination medications did not significantly increase serious psychological distress over the treatment period compared to other medication options. CONCLUSIONS: Both varenicline and combination pharmacotherapy were effective and did not increase psychological distress for up to 6 months in smokers with co-morbidities treated at a specialty clinic. |
| | |
Authors:
|
Michael B Steinberg; Michelle T Bover; Donna L Richardson; Amy C Schmelzer; Jill M Williams; Jonathan Foulds |
Publication Detail:
|
Type: Journal Article Date: 2010-10-16 |
Journal Detail:
|
Title: Drug and alcohol dependence Volume: 114 ISSN: 1879-0046 ISO Abbreviation: Drug Alcohol Depend Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-02-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7513587 Medline TA: Drug Alcohol Depend Country: Ireland |
Other Details:
|
Languages: eng Pagination: 77-81 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Division of General Internal Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, 125 Paterson Street, Suite 2300, New Brunswick, NJ 08903, USA; Tobacco Dependence Program, University of Medicine and Dentistry of New Jersey-School of Public Health, 317 George Street, Suite 210, New Brunswick, NJ 08901, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A child with longitudinal cleavage of the upper extremity: treatment and etiology considerations.
Next Document: Chronic alcohol consumption impairs visuo-spatial associative memory in periadolescent rhesus monkey...